Provider–client rapport in pre-exposure prophylaxis delivery: a qualitative analysis of provider and client experiences of an implementation science project in Kenya

Figures & data

Table 1. Characteristics of interviewed health care providers and adolescent girls and young women

1. Health care providers
Characteristic	Number
Health care providers interviewed	15
Median age (IQR)	30 (29–42)
Female	9 (60%)
POWER staff	10 (67%)
Primary role during POWER study
Health care provider	10 (67%)
HIV testing services counsellor	3 (30%)
Clinician^1	6 (60%)
Adherence counsellor	1 (10%)
Other key informant^2	5 (33%)
2. Adolescent girls and young women
Characteristic	Number
Adolescent girls and young women interviewed	38
Median age (IQR)	21 (19–24)
Single marital status	22 (58%)
Median number of living children	1 (0–1)
Multiple sexual partners	8 (21%)
Unknown partner HIV status	21 (55%)
Condom use
Always	4 (11%)
Never	16 (42%)
Inconsistent	18 (47%)
Positive chlamydia/gonorrhea	10 (26%)
Partner has other sexual partners
Yes	4 (11%)
No	2 (5%)
Don’t know	32 (84%)
Breastfeeding	5 (13%)
Ever pregnant	25 (65%)

¹ Includes nurses and doctors/medical officers

² Includes individuals whose primary role in POWER focused on research activities (as opposed to direct service provision) as well as individuals who were not directly involved in POWER but who, through their involvement in PrEP delivery in the region, could potentially provide relevant information about Kenya’s PrEP delivery landscape and/or PrEP delivery to Kenyan AGYW.

IQR – interquartile range.

POWER – prevention options for women evaluation research.

Table 2. Categories of adolescent girls and young women interviewed

Participant category	Definition	Number interviewed (n = 38)	Median duration on PrEP in days (interquartile range)
Initial refusers	Participants who declined PrEP at enrolment (but may or may not have started later)	10 (26%)	0
Non-continuous users	Participants who initiated PrEP at enrolment and had a recently scheduled month 3 or month 6 visit and pharmacy records indicate late (within 30 days of scheduled pick-up), missed (did not completely attend their next scheduled pick-up) or declined PrEP pill pick-up	9 (23%)	93 (86–150)
Continuous users	Participants who initiated PrEP at enrolment and continued PrEP use over 6-month period with no gaps in pill coverage based on pill dispensing records	7 (18%)	108 (93–120)
Initial acceptors	Participants who initiated PrEP at enrolment	6 (15%)	47 (42–47)
Special cases	Participants whose unique circumstances or perspectives stood out and whose experiences could inform PrEP delivery, including participants who sero-converted to HIV	4 (10%)	145 (70–188)
Restarters	Participants who initiated PrEP and pharmacy records show a break in PrEP use for more than 30 days before a PrEP pill pick-up at a later clinic visit	2 (5%)	118 (118–118)